ID: ALA1277977

Max Phase: Preclinical

Molecular Formula: C16H12ClFN2S

Molecular Weight: 283.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[n+]1cc2c(c3ccccc31)Nc1ccc(F)cc1S2.[Cl-]

Standard InChI:  InChI=1S/C16H11FN2S.ClH/c1-19-9-15-16(11-4-2-3-5-13(11)19)18-12-7-6-10(17)8-14(12)20-15;/h2-9H,1H3;1H

Standard InChI Key:  CNOROWCLYTWMGV-UHFFFAOYSA-N

Associated Targets(Human)

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Lewis lung carcinoma cell line 1243 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 283.35Molecular Weight (Monoisotopic): 283.0700AlogP: 4.01#Rotatable Bonds: 0
Polar Surface Area: 15.91Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: -0.37CX LogD: -0.37
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.49Np Likeness Score: -0.37

References

1. Zięba A, Sochanik A, Szurko A, Rams M, Mrozek A, Cmoch P..  (2010)  Synthesis and in vitro antiproliferative activity of 5-alkyl-12(H)-quino[3,4-b] [1,4]benzothiazinium salts.,  45  (11): [PMID:20813435] [10.1016/j.ejmech.2010.07.035]

Source